Cipla share price

Cipla Share Price Dips 7% Today यूएसएफडीए (USFDA) की ओर से 6 से 17 फरवरी के बीच कंपनी की मैन्युफैक्चरिंग ...

कंपनी ने शनिवार को शेयर बाजार को सूचना देते हुए कहा कि यूएस फूड और ड्रग एडमिनिस्ट्रेशन (USFDA) की ओर से 6 से 17 फरवरी के बीच कंपनी की मैन्युफैक्चरिंग फैसिलिटी का करंट गुड मैन्युफैक्चरिंग प्रैक्टिस (cGMP) के तहत निरीक्षण किया गया था। इसके बाद कंपनी को यूएसएफडीए से 'फॉर्म 483' दिया गया है, जिसमें मैन्युफैक्चरिंग फैसिलिटी को लेकर आठ ओवजर्वेशन दी गई हैं। कंपनी ने आगे कहा कि इसके लिए वे यूएसएफडीए के साथ मिलकर काम कर रहे हैं। नई दिल्ली, बिजनेस डेस्क। देश की दिग्गज फार्मा कंपनी सिप्ला के शेयर में आज शुरुआती कारोबार में ही सात प्रतिशत तक की बड़ी गिरावट देखने को मिली। कंपनी के शेयर में गिरावट का कारण अमेरिकी हेल्थ रेगुलेटर की ओर से मध्य प्रदेश की पीथमपुर स्थित मैन्युफैक्चरिंग फैसिलिटी का निरीक्षण करने के बाद आठ ओवजर्वेशन के साथ 'फॉर्म 483' दिया जाना है। Cipla Share Price Dips 7% Today यूएसएफडीए (USFDA) की ओर से 6 से 17 फरवरी के बीच कंपनी की मैन्युफैक्चरिंग फैसिलिटी का निरीक्षण किया गया था जिसके बाद कंपनी को फॉर्म 483 जारी किया गया है।(जागरण फाइल फोटो)

India Business News: The US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing ...

The stock declined 6.78 per cent to Rs 956.20 on the BSE. At the NSE, it tanked 6.87 per cent to Rs 955.25.

Cipla share price: The stock was last seen trading lower than 5-day, 20-, 50-, 100- and 200-day moving averages. The counter's 14-day relative strength ...

TRENDING Meanwhile, Indian equity benchmarks slipped into the red in afternoon deals as losses in banks and financials countered gains in technology and automobile shares. That said, the stock has moved 8.66 per cent higher from its one-year low level of Rs 880, touched on February 24, 2022. There were 57,150 buy orders against sell orders of 50,843 shares. The scrip has a one-year beta of 0.46, indicating low volatility. The counter's 14-day relative strength index (RSI) came at 28.40. Targets will be Rs 1,043-1,084 in the coming days," said AR Ramachandran from Tips2trades. On conclusion of the inspection, the Company has received 8 inspectional observations in Form 483," Cipla stated in an exchange filing. Shares of Cipla fell sharply in Monday's trade after the drug major's Pithampur manufacturing facility received eight inspectional observations in Form 483 from the United States Food and Drug Administration (USFDA). "We hereby notify that the USFDA conducted a current Good Manufacturing Practices (cGMP) inspection at our Pithampur manufacturing facility from February 6-17, 2023. The company's stock has a price-to-equity (P/E) ratio of 29.46. The stock was last seen trading lower than 5-day, 20-, 50-, 100- and 200-day moving averages.

The company said it will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

The stock of pharmaceutical company was trading at its lowest level since July 2022. The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time, [Cipla](/topic/cipla) said. [ Business Standard App ](/app) for latest [Business News](/) and [ Market News ](/markets). [Cipla](/topic/cipla) said in an exchange filing. [Cipla](/topic/cipla) dipped 7 per cent to Rs 956.20 on the BSE in Monday’s intra-day trade after the company said that the United States Food and Drug Administration (USFDA) issued Form 483 with 8 observations after the inspection of its Pithampur manufacturing facilities.

Share Market LIVE Updates: Benchmark indices are trading in the red Monday with Sensex 300 down and Nifty trading below 17900. Cipla, Adani Enterprises ...

(Read More) Economists at Goldman Sachs added one more hike by the Fed in June to their forecast, meaning they see its key short-term rate ultimately rising to a range of 5.25% to 5.50%. A total of two stocks have been put under the ban for trade on Monday, February 20, 2023, under the futures and options (F&O) segment by the National Stock Exchange (NSE). Much of the decline can be attributed to RBI's intervention and a rise in the cost of imported goods in recent times. However, a footnote in the filing said that the cash balances included “cash & cash equivalents, bank balances, current investments, the market value of marketable securities (non-current investments), the balance held as margin money and deposit for more than 12 months". In a 14 February filing to the exchange, the Adani group said it had ₹31,646 crore ($3.9 billion) in cash and cash equivalents as of 31 December 2022. The initial public offering (IPO) of Macfos Ltd, which opened for public subscription on Friday, February 17, 2023, has been oversubscribed over 8 times on day 1, led by demand from retail investors. Its shares have lost more three-quarters of their value since the short seller report was published on Jan. Gross margins expanded 200bp QoQ (flat YoY) at 39%. Bharat Dynamics shares have been in uptrend for some time as the defense company has struck 10 MoU (memoranda of Understanding ) with Indian and overseas companies during the recently concluded Aero India 2023. Noted Iranian-American economist Nouriel Roubini expects foreign direct investment (FDI) flowing out of China and coming to India. West Texas Intermediate (WTI) crude for March, which expires on Tuesday, was at $76.89 a barrel, up 55 cents or 0.7%.

Cipla share price today BSE, NSE: Cipla shares suffered steep losses on Monday after the drug maker said US health regulator had issued eight observations ...

The third-party service providers that generate these cookies, such as, social media platforms, have their own privacy policies, and may use their cookies to target advertisement to you on other websites, based on your visit to our sites. These cookies collect information about your activities on our sites as well as other sites to provide you targeted advertising. However, this will not prevent the sites from placing further cookies on your device unless and until you adjust your Internet browser setting as described above. If you subscribe to a newsletter or otherwise register with the Sites, these cookies may be correlated to you. Without these essential cookies we may not be able to provide certain services or features and our site will not perform as smoothly for you as we would like. We use persistent cookies to improve your experience of using the sites. However, if you select this setting you may be unable to access certain parts of the sites. Zeenews.com use cookies and other technologies to store information in your web browser or on your mobile phone, tablet, computer, or other devices (collectively "devices") that allow us to store and receive certain pieces of information whenever you use or interact with our zeenews.india.com applications and sites. These third-party service providers use persistent Cookies to help us improve user experience, manage our site content, and analyse how users navigate and utilize the sites. A cookie is a small text file that can be stored on and accessed from your device when you visit one of our sites, to the extent you agree. Likewise, if you share any content on this website through social networks (for example by clicking a Facebook “like” button or a “Tweet” button) you may be sent cookies from these websites. zeenews.india.com understands that your privacy is important to you and we are committed for being transparent about the technologies we use.

The United States Food and Drug Administration has issued a form 483 along with eight observations for Cipla's Pithampur / Indore manufacturing facility.

It has an overweight rating on Cipla with a price target of Rs 1,210. JPMorgan calls this facility as among the key ones for Cipla besides the Goa and Invagen plant in the US. Brokerage firm Incred says that both the products are likely to see a worse competitive landscape in financial year 2025 compared to the next financial year.

Stock Market LIVE: इस हफ्ते बाजार की नजर विदेशी निवेशकों के निवेश, क्रूड की कीमतों के साथ डॉलर ...

इंडेक्स में विप्रो का शेयर टॉप लूजर है. शेयर बाजार की सुस्ती में भी फार्मा कंपनी सिप्ला का शेयर 5% से ज्यादा टूट गया है. इसमें अल्ट्राटेक सीमेंट का शेयर इंडेक्स में टॉप गेनर है. इस हफ्ते बाजार की नजर विदेशी निवेशकों के निवेश, क्रूड की कीमतों के साथ डॉलर के मुकाबले रुपए की चाल पर होगी. BSE पर Cipla का शेयर 5% फिसल गया है. इससे पहले शुक्रवार को सेंसेक्स 316 अंकों की गिरावट के साथ 61,002 पर और निफ्टी 91 अंक नीचे 17,944 पर बंद हुआ था.

दिग्गज फार्मा कंपनी सिप्ला (Cipla Share Price) के शेयरों में सोमवार को भारी गिरावट देखने को ...

दिग्गज फार्मा कंपनी सिप्ला (Cipla Share Price) के शेयरों में सोमवार को भारी गिरावट देखने को मिली है। कंपनी के शेयर आज 7 प्रतिशत से अधिक लुढ़क गए। शेयरों में गिरावट की बड़ी वजह एक जांच बनी है। शेयर बाजार को दी जानकारी में सिप्ला ने बताया है कि यूनाइटेड स्टेट फूड एंड ड्र्ग्स एडमिनिस्ट्रेशन (USFDA) ने पीतमपुरा मैन्युफैक्चरिंग प्लांट की जांच की है। इस खबर की जानकारी जैसे ही निवेशकों को मिली उसके बाद से शेयरों में गिरावट देखी गई। शेयर बाजार को दी जानकारी में सिप्ला ने बताया है कि यूनाइटेड स्टेट फूड एंड ड्र्ग्स एडमिनिस्ट्रेशन (USFDA) ने पीतमपुरा मैन्युफैक्चरिंग प्लांट की जांच की है। इसी के बाद कंपनी के शेयरों में गिरावट आई है। [हिंदी न्यूज़](/) [बिजनेस](/business/)1 जांच के बाद दिग्गज कंपनी ने खोया निवेशकों का विश्वास!

Shares of Cipla made a weak opening on domestic bourses on Monday, tumbling nearly 7% in an otherwise positive broader market after the U.S. drug regulator ...

The sector heavyweight has gained 7% in the last 12 months as compared to 7% fall in the healthcare index. The revenue from operations climbed 5.2% to ₹5,730.08 as against ₹5,442.86 in the same quarter last fiscal. In the last one month, the stock has shed 8.5% as compared to nearly 4% fall in the BSE benchmark Sensex. For the three month period ended December 31, 2022, Cipla reported 9.93% growth in consolidated net profit to ₹800.96 crore as compared to ₹728.60 crore in the corresponding quarter last fiscal. In August last year, the USFDA had issued six observations for Cipla’s Goa plant, which underwent inspection from August 16-26, 2022. Extending opening losses, the stock declined as much as 6.8% to hit a low of ₹956.20 in the first hour of the trade so far.

नई दिल्ली: शेयर बाजार (Stock Market) में आज सुबह से ही तेजी देखी गई। बाजार हरे निशान पर खुला था।